NCT03320174View on ClinicalTrials.gov

Long-Term Safety Study of Tafenoquine

PHASE2CompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

October 5, 2017

Primary Completion Date

July 13, 2021

Study Completion Date

July 13, 2021

Conditions
Healthy Volunteers
Interventions
DRUG

Tafenoquine

Tafenoquine 200mg

OTHER

Placebo

Placebo

Trial Locations (3)

6009

Linear Clinical Research, Nedlands

78503

Valley Retina Institute, McAllen

80909

Retina Consultants of Southern Colorado, Colorado Springs

Sponsors
All Listed Sponsors
lead

60 Degrees Pharmaceuticals LLC

INDUSTRY

NCT03320174 - Long-Term Safety Study of Tafenoquine | Biotech Hunter | Biotech Hunter